171 related articles for article (PubMed ID: 8600037)
1. Prognostic factors in urachal adenocarcinoma. A study in 41 specimens of DNA status, proliferating cell-nuclear antigen immunostaining, and argyrophilic nucleolar-organizer region counts.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Hum Pathol; 1996 Mar; 27(3):240-7. PubMed ID: 8600037
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
3. Argyrophilic nucleolar-organizer region counts and DNA status in bronchioloalveolar epithelial hyperplasia and adenocarcinoma of the lung.
Nakanishi K; Hiroi S; Kawai T; Suzuki M; Torikata C
Hum Pathol; 1998 Mar; 29(3):235-9. PubMed ID: 9496825
[TBL] [Abstract][Full Text] [Related]
4. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
5. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
Pich A; Chiarle R; Chiusa L; Palestro G
Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
10. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
11. DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.
Cappiello J; Nicolai P; Antonelli AR; Facchetti F; Cadei M; Cornacchiari A; Grigolato PG
Eur Arch Otorhinolaryngol; 1995; 252(6):353-8. PubMed ID: 8679155
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in oesophageal cancer.
Kuwano H; Sumiyoshi K; Nozoe T; Yasuda M; Watanabe M; Sugimachi K
Eur J Surg Oncol; 1995 Aug; 21(4):368-73. PubMed ID: 7664900
[TBL] [Abstract][Full Text] [Related]
13. The prognostic importance of the nucleolar organizer region (AgNOR), Ki-67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
Ozdemir BH; Ozdemir OG; Sertçelik A
APMIS; 2001 Jun; 109(6):428-34. PubMed ID: 11506474
[TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer.
Oyama T; Mitsudomi T; Mizoue T; Ohgami A; Osaki T; Nakanishi R; Yasumoto K
Surg Oncol; 1995; 4(2):83-9. PubMed ID: 7551263
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
[TBL] [Abstract][Full Text] [Related]
18. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
[TBL] [Abstract][Full Text] [Related]
20. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
